Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Blood drug"'
Autor:
Michele Iuliani, Alfredo Berruti, Giuseppe Tonini, Francesca Vignani, Bruno Vincenzi, Consuelo Buttigliero, Alice Zoccoli, Daniele Santini, Giulia Ribelli, Giorgio V. Scagliotti, Valentina Bertaglia, Marcello Tucci, Francesco Pantano, Marco Fioramonti
Publikováno v:
Onkourologiâ, Vol 11, Iss 4, Pp 81-88 (2015)
Oncotarget, 6 (14
Oncotarget
Oncotarget, 6 (14
Oncotarget
Abiraterone acetate (ABI) is associated not only with a significant survival advantage in both chemotherapy-naive and -treated patients with metastatic castration-resistant prostate cancer (mCRPC), but also with a delay in time to development of Skel
Autor:
Michael Schiff, Xianhuang Zhou, S. Kelly, J E Huffstutter, V Rodriguez-Valverde, K Bahrt, Tracy Li, C Pritchard, Patrick Durez, Mark C. Genovese, M. Le Bars
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 68, no. 11, p. 1708-1714 (2009)
Annals of the Rheumatic Diseases, Vol. 68, no. 11, p. 1708-1714 (2009)
Objective: To assess the safety, tolerability and efficacy of abatacept in patients with rheumatoid arthritis (RA) who had failed anti-tumour necrosis factor (TNF) therapy and were switched to abatacept directly or after completing washout. Methods:
Autor:
Phare Mujinja, Stephen Ed Nsimba
Publikováno v:
Asian Pacific Journal of Tropical Medicine. 3(6):451-453
ObjectiveTo observe and assess the compliance to sulfadoxine-pyrimethamine (SP) one and a half years after phasing out chloroquine (CQ) in Mkuranga District, Coast region, Tanzania.MethodsA randomly controlled baseline community study was conducted i
Autor:
Tim Ramsay, G. Le Gal, Michael J. Kovacs, Karine Lacut, Marc Carrier, David A. Anderson, Arnaud Perrier, Linda M. Vickars, Isabelle Chagnon, Susan Solymoss, M. T. Betancourt, Susan R. Kahn, P. S. Wells, Marc A. Rodger, Richard H. White, Mark Crowther
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2010, 126 (3), pp.222-6. ⟨10.1016/j.thromres.2010.06.007⟩
Thrombosis Research, Vol. 126, No 3 (2010) pp. 222-226
Thrombosis Research, Elsevier, 2010, 126 (3), pp.222-6. ⟨10.1016/j.thromres.2010.06.007⟩
Thrombosis Research, Vol. 126, No 3 (2010) pp. 222-226
International audience; INTRODUCTION: Case-control studies suggest that elevated lipoprotein (a) (Lp(a)) is a risk factor for first venous thromboembolism (VTE). Lp(a) has not been prospectively investigated as a possible risk factor for recurrent VT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634d9beeb7c21a37b299b2c7ba0255e1
https://hal.univ-brest.fr/hal-00722005
https://hal.univ-brest.fr/hal-00722005
Publikováno v:
Cold Spring Harbor Perspectives in Medicine. 5:a017822-a017822
Tuberculosis is an airborne infectious disease treated with combination therapeutic regimens. Adherence to long-term antituberculosis therapy is crucial for maintaining adequate blood drug level. The emergence and spread of drug-resistant Mycobacteri